Beximco Pharmaceuticals Limited

LSE:BXP.L

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

🌿 Fertilizers

🧴 Personal Care

Location

Bangladesh

Market Cap

USD 310.43 M

Share Price

USD 0.53

Avg Daily Volume

26,694

Change (1 day)

-0.67%

Change (1 year)

5.75%

Change (YTD)

7.76%

Beximco Pharmaceuticals Limited EBITDA for the year ending July 13, 2025: N/A

Beximco Pharmaceuticals Limited EBITDA is NA for the year ending July 13, 2025. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Competitors

Johnson & Johnson

USD 156.90

JNJ

-0.79 -0.50%

Divi's Laboratories Limited

USD 79.54

DIVISLAB.NS

-0.27 -0.34%

ALK-Abelló A/S

USD 30.42

ALK-B.CO

-0.16 -0.54%

Nahdi Medical Company

USD 34.29

4164.SR

-0.21 -0.61%

Rohto Pharmaceutical Co.,Ltd.

USD 13.97

4527.T

+0.05 0.35%

Hypera S.A.

USD 4.85

HYPE3.SA

-0.04 -0.79%

J. B. Chemicals & Pharmaceuticals Limited

USD 18.72

JBCHEPHARM.NS

-0.11 -0.56%

Almirall, S.A.

USD 12.79

ALM.MC

-0.08 -0.64%

Organon & Co.

USD 9.94

OGN

-0.08 -0.80%

Dermapharm Holding SE

USD 40.03

DMP.DE

-0.92 -2.24%

Caplin Point Laboratories Limited

USD 23.55

CAPLIPOINT.NS

-0.27 -1.14%

Eli Lilly and Company

USD 793.01

LLY

+2.36 0.30%

AbbVie Inc.

USD 192.45

ABBV

-2.55 -1.31%

Roche Holding AG

USD 343.65

RO.SW

-5.43 -1.55%

AstraZeneca PLC

USD 140.89

AZN.L

-3.33 -2.31%

Merck & Co., Inc.

USD 83.36

MRK

-0.66 -0.79%

Amgen Inc.

USD 295.27

AMGN

-5.10 -1.70%

Pfizer Inc.

USD 25.65

PFE

-0.13 -0.50%

Gilead Sciences, Inc.

USD 109.64

GILD

-4.90 -4.28%

Key Data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)